Clinical Trials for Acquired Resistance to KRAS G12C Inhibitor

Find clinical trials for acquired resistance to kras g12c inhibitor. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers

NCT ID: NCT05786924

This clinical trial is studying a new medication called BDTX-4933, which is being tested in patients with certain types of advanced cancers that have specific genetic mutations, like those found in...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States, New York, New York, United States +14 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions